Edition:
United States

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

1,002.25INR
6:25am EDT
Change (% chg)

Rs-2.95 (-0.29%)
Prev Close
Rs1,005.20
Open
Rs1,009.90
Day's High
Rs1,009.90
Day's Low
Rs997.00
Volume
1,900,325
Avg. Vol
1,919,641
52-wk High
Rs1,573.60
52-wk Low
Rs917.55

Latest Key Developments (Source: Significant Developments)

India's Lupin gets FDA nod for generic flagyl tablets
Wednesday, 13 Sep 2017 05:43am EDT 

Sept 13 (Reuters) - Lupin Ltd :Says Lupin receives FDA approval for generic flagyl tablets.Metronidazole tablets USP indicated in treating wide variety of infections caused by certain types of bacteria, other infectious organisms.  Full Article

India's Lupin gets U.S. FDA approval for generic vibra-tabs tablet
Monday, 11 Sep 2017 04:21am EDT 

Sept 11 (Reuters) - Lupin Ltd :Says Lupin receives FDA approval for generic vibra-tabs tablet.Says doxycycline hyclate tablet is indicated in treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne.  Full Article

Lupin launches generic benicar tablets in the U.S.
Monday, 4 Sep 2017 03:08am EDT 

Sept 4 (Reuters) - Lupin Ltd :Says lupin launches generic benicar tablets in the U.S..  Full Article

India's Lupin launches generic fosrenol chewable tablets in the U.S.
Thursday, 31 Aug 2017 02:59am EDT 

Aug 31 (Reuters) - Lupin Ltd :Launches generic fosrenol chewable tablets in the US.  Full Article

Lupin launches generic Seroquel tablets in U.S.‍​
Wednesday, 23 Aug 2017 05:49am EDT 

Aug 23 (Reuters) - Lupin Ltd ::Says co launches generic seroquel xr tablets in u.s.‍​.Says drug used for treatment of schizophrenia, acute manic or mixed episodes in bipolar i disorder‍​.  Full Article

Lupin gets EIR from U.S. FDA for Aurangabad inspection
Monday, 21 Aug 2017 08:09am EDT 

Aug 21 (Reuters) - Lupin Ltd :Says receives EIR from U.S. FDA for Aurangabad, April 2017 inspection.Says EIR closes all outstanding US FDA inspections at Lupin’s Aurangabad facility.  Full Article

Lupin appoints Manju Deshbandhu Gupta as chairman
Friday, 11 Aug 2017 06:36am EDT 

Aug 11 (Reuters) - Lupin Ltd :Says appoints Manju Deshbandhu Gupta as chairman.  Full Article

Lupin gets U.S. FDA approval for generic Crestor tablets
Thursday, 3 Aug 2017 04:35am EDT 

Aug 3 (Reuters) - Lupin Ltd :Says receives FDA approval for generic Crestor tablets.Says approval for Rosuvastatin Calcium tablets 5 mg, 10 mg, 20 mg and 40 mg.  Full Article

Lupin says Q1 results below co's expectations
Wednesday, 2 Aug 2017 04:27am EDT 

Aug 2 (Reuters) - Lupin Ltd :Says Q1, FY2018 results have "been below our own expectations".Results below expectations on count of higher than anticipated price erosion in select products, disruption on count of GST, rupee appreciation.  Full Article

India's Lupin June-qtr consol profit down about 59 pct
Wednesday, 2 Aug 2017 04:16am EDT 

Aug 2 (Reuters) - Lupin Ltd ::June quarter consol net profit 3.58 billion rupees versus profit of 8.82 billion rupees last year.Consensus forecast for June quarter consol profit was 4.79 billion rupees.June quarter consol total revenue from operations 38.70 billion rupees versus 44.68 billion rupees last year.  Full Article

BRIEF-India's Lupin gets FDA nod for generic flagyl tablets

* Says Lupin receives FDA approval for generic flagyl tablets